Challenging ChatGPT 3.5 in Senology—An Assessment of Concordance with Breast Cancer Tumor Board Decision Making
Sebastian Griewing(Philipps University of Marburg), Jelena Boekhoff(Philipps University of Marburg), Niklas Gremke(Philipps University of Marburg), Sebastian Kühn(Leibniz Institute of Polymer Research), Uwe Wagner(German Society of Surgery), Michael Lingenfelder(Philipps University of Marburg)
Cited by 70
Related Papers
mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
|Nature Communications|2020|171
Evolution of publicly available large language models for complex decision-making in breast cancer care
|Archives of Gynecology and Obstetrics|2024|28
Positive association between body height and breast cancer prevalence: a retrospective study with 135,741 women in Germany
|Breast Cancer Research and Treatment|2022|19
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
|Signal Transduction and Targeted Therapy|2025|19
Proof-of-concept study of a small language model chatbot for breast cancer decision support – a transparent, source-controlled, explainable and data-secure approach
|Journal of Cancer Research and Clinical Oncology|2024|16